Institute strategi seminar at Lysebu Hotel

Lysebu Hotel
![]() | ![]() | ![]() | ![]() |
Plenary lectures
| Session 1: | |
![]() | Gunnar Sæter, head physician, Dept. of medical treatment, The cancer clinic The CCC concept and diagnosis based programs: The role of the Institute seen from a Comprehenvise Cancer Center perspective. |
![]() | Øystein Fodstad, Department head, Dept. of Tumor Biology Collaboration in modern cancer research |
| Session 2: | |
![]() | Kirsten Skarstad, group leader, Dept. of Cell Biology The role of basic research at the institute |
![]() | Tor Erik Rusten, post doc, Dept. of Biochemistry Recruitment and career opportunities |
| Session 3: | |
![]() | Sigbjørn Smeland, Head of Cancer Clinic The research fraud case: status, internal process and further steps |
![]() | Knut W. Reuter, secretariat leader, National Ethical Committee Research fraud and research ethics |
| Session 4 | |
![]() | Åge Danielsen, director Rikshospitalet-Radiumhospitalet HF Challenges for the institution and the role of the Institute for Cancer Research |
![]() | Erlend B. Smeland, Institute director Institute for Cancer Research The Institute in a period of change |
Group work
| Themes for discussion for the group work: | Group conclusions presented by: |
| Strong and weak points of the Institute | Kirsten Sandvig Edgar Rivedal |
| Organisational culture | Jostein Dahle |
| Strategy relating to research fields - what to emphasize | Harald Stenmark |
| Internal collaboration at the Institute | Ragnhild Lothe |
| External collaboration | Gustav Gaudernack |
| Financing. Innovation and commercialization | Eivind Hovig |
| Recruitment and carreer opportunities. surface areas/space/functions | Tor Erik Rusten |
















Go back
Print this page
E-mail this page
